Technical Analysis for CARA - Cara Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| New Downtrend | Bearish | -2.24% | |
| Wide Bands | Range Expansion | -2.24% | |
| Wide Bands | Range Expansion | 1.89% | |
| 180 Bearish Setup | Bearish Swing Setup | -3.22% | |
| NR7 | Range Contraction | -3.22% | |
| Narrow Range Bar | Range Contraction | -3.22% | |
| Inside Day | Range Contraction | -3.22% | |
| Wide Bands | Range Expansion | -3.22% |
| Alert | Time |
|---|---|
| Up 3% | about 21 hours ago |
| Rose Above Previous Day's High | about 21 hours ago |
| Up 2% | about 22 hours ago |
| 60 Minute Opening Range Breakout | about 22 hours ago |
| Rose Above 10 DMA | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Clinical Trial Chronic Pain Amines Acute And Chronic Pain Piperidines Mesoblast
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Clinical Trial Chronic Pain Amines Acute And Chronic Pain Piperidines Mesoblast
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.665 |
| 52 Week Low | 0.5 |
| Average Volume | 663,279 |
| 200-Day Moving Average | 1.38 |
| 50-Day Moving Average | 0.83 |
| 20-Day Moving Average | 0.77 |
| 10-Day Moving Average | 0.70 |
| Average True Range | 0.07 |
| RSI (14) | 41.52 |
| ADX | 26.23 |
| +DI | 14.16 |
| -DI | 28.90 |
| Chandelier Exit (Long, 3 ATRs) | 0.74 |
| Chandelier Exit (Short, 3 ATRs) | 0.86 |
| Upper Bollinger Bands | 0.94 |
| Lower Bollinger Band | 0.61 |
| Percent B (%b) | 0.23 |
| BandWidth | 43.16 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.03 |
| MACD Histogram | -0.0088 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.75 | ||||
| Resistance 3 (R3) | 0.76 | 0.74 | 0.74 | ||
| Resistance 2 (R2) | 0.74 | 0.73 | 0.74 | 0.74 | |
| Resistance 1 (R1) | 0.71 | 0.71 | 0.71 | 0.71 | 0.73 |
| Pivot Point | 0.70 | 0.70 | 0.69 | 0.69 | 0.70 |
| Support 1 (S1) | 0.67 | 0.68 | 0.66 | 0.66 | 0.63 |
| Support 2 (S2) | 0.65 | 0.67 | 0.65 | 0.63 | |
| Support 3 (S3) | 0.62 | 0.65 | 0.63 | ||
| Support 4 (S4) | 0.61 |
